LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)

A pharmaceutical composition used for prevention and/or treatment of a peroxisome proliferator-activated receptor-related disease, which comprises an extract of one or more plants selected from the following:

• Serenoa repens, Acanthopanax senticosus, Euterpe oleracea, Elettaria cardamomum, Angelica archangelica, Psidium guajava, Prumus spinosa, Eleagnus multiflora, Ligusticum chuaxiong, Cannabis sativa, Sambucus nigra, Adinandra nitida, Passiflora incarnata, Peucedanum japonicum, Pimpinella anisum, Vitex agnus-castus, Withania somnifera, Calluna vulgaris, Crataegus monogyna, Linum usitatissimum, Pleurotus ferulae, Robinia pseudoacacia, and Acanthopanax sessiliflorus
• and a pharmaceutically acceptable additive.

A food or beverage product, which comprises an extract of one or more plants selected from the following:

• Serenoa repens, Acanthopanax senticosus, Euterpe oleracea, Elettaria cardamomum, Angelica archangelica, Psidium guajava, Prumus spinosa, Eleagnus multiflora, Ligusticum chuaxiong, Cannabis sativa, Sambucus nigra, Adinandra nitida, Passiflora incarnata, Peucedanum japonicum, Pimpinella anisum, Vitex agnus-castus, Withania somnifera, Calluna vulgaris, Crataegus monogyna, Linum usitatissimum, Pleurotus ferulae, Robinia pseudoacacia, and Acanthopanax sessiliflorus
• and an additive acceptable for food or beverage purposes.

An anti-obesity agent, which comprises an extract of one or more plants selected from the group consisting of Sambucus nigra, Pimpinella anisum, Crataegus monogyna and Adinandra nitida as an active ingredient.

A method for prevention and/or treatment of a peroxisome proliferator-activated receptor-related disease, which comprises administering to a subject in need of such prevention and/or treatment, a pharmaceutical composition comprising an extract of one or more plants selected from the following:

• Serenoa repens, Acanthopanax senticosus, Euterpe oleracea, Elettaria cardamomum, Angelica archangelica, Psidium guajava, Prumus spinosa, Eleagnus multiflora, Ligusticum chuaxiong, Cannabis sativa, Sambucus nigra, Adinandra nitida, Passiflora incarnata, Peucedanum japonicum, Pimpinella anisum, Vitex agnus-castus, Withania somnifera, Calluna vulgaris, Crataegus monogyna, Linum usitatissimum, Pleurotus ferulae, Robinia pseudoacacia, and Acanthopanax sessiliflorus.

Use for the manufacture of a pharmaceutical composition used for prevention and/or treatment of a peroxisome proliferator-activated receptor-related disease, wherein the pharmaceutical composition comprises an extract of one or more plants selected from the following:

• Serenoa repens, Acanthopanax senticosus, Euterpe oleracea, Elettaria cardamomum, Angelica archangelica, Psidium guajava, Prumus spinosa, Eleagnus multiflora, Ligusticum chuaxiong, Cannabis sativa, Sambucus nigra, Adinandra nitida, Passiflora incarnata, Peucedanum japonicum, Pimpinella anisum, Vitex agnus-castus, Withania somnifera, Calluna vulgaris, Crataegus monogyna, Linum usitatissimum, Pleurotus ferulae, Robinia pseudoacacia, and Acanthopanax sessiliflorus.

A method for prevention and/or treatment of obesity, which comprises administering to a subject in need of such prevention and/or treatment, an anti-obesity agent comprising an extract of one or more plants selected from the group consisting of Sambucus nigra, Pimpinella anisum, Crataegus monogyna and Adinandra nitida.

Use for the manufacture of an anti-obesity agent used for prevention and/or treatment of obesity, wherein the anti-obesity agent comprises an extract of one or more plants selected from the group consisting of Sambucus nigra, Pimpinella anisum, Crataegus monogyna and Adinandra nitida.